Drug Profile
Research programme: nociceptin receptor agonists - Schering-Plough
Alternative Names: SCH 225288; SCH 655842Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Schering-Plough
- Class Benzyl compounds; Nortropanes
- Mechanism of Action Nociceptin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anxiety disorders; Cough
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Anxiety-disorders in USA (PO)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Cough in USA (PO)
- 21 Oct 2009 Pharmacodynamics data from preclinical trials in Anxiety disorders presented at the 39th Annual Meeting of the Society for Neuroscience (SfN-2009)